Oral contraceptive use and risk of breast cancer: A meta-analysis of prospective cohort studies

European Journal of Contraception and Reproductive Health Care

Volumn 17, Issue 6, 2012, Pages 402-414

  Hang, Zhu ^a   Xun, Lei ^a   Jing, Feng ^a   Yang, Wang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Meta analysis; Oral contraceptive; Prospective cohort study

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

BREAST CANCER; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; DATA BASE; DOSE RESPONSE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HUMAN; ORAL CONTRACEPTION; POSTMENOPAUSE; PREMENOPAUSE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLICATION; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW;

ADULT; AGED; BREAST NEOPLASMS; COHORT STUDIES; CONTRACEPTIVES, ORAL; DATABASES, FACTUAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MIDDLE AGED; RISK; YOUNG ADULT;

EID: 84869427231     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.3109/13625187.2012.715357     Document Type: Review

References (41)

1. CancerStats Incidence 2008-UK. Accessed 1 June 2012 from: http://info.cancerresearchuk.org/prod-consump/groups/cr-common/@nre/@sta/ documents/generalcontent/cr-072111.pdf
2. American Cancer Society. Cancer facts and figures 2011 . Accessed 1 June 2012 from: http://www.cancer. org/acs/groups/content/@epidemiologysurveilance/ documents/document/acspc-029771.pdf
3. Yearbook of Chinese health statistics, 2010. Accessed 1 June 2012 from: http://www.moh.gov.cn/publicfiles/business/htmlfiles/zwgkzt/ptjnj/year2010/ index 2010.html.
4. Yang PS, Yang Y L, Liu CL, et al. A case-control study of breast cancer in Taiwan-a low incidence area. Br J Cancer 1997; 75: 752-6.
5. Ng EH, Gao F, Ji CY, et al. Risk factors for breast carcinoma in Singaporean Chinese women: The role of central obesity. Cancer 1997; 80: 725-31. (Pubitemid 27339828)
6. United Nations. World contraceptive use 2011. Accessed 5 June 2012 from: http://www.un.org/esa/population/publications/contraceptive2011/wallchart-front. pdf
7. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12. (Pubitemid 30214957)
8. Greenland S, Longecker M P. Methods for trend estimation from summarized dose-response data, with application to meta-analysis. Am J Epidemiol 1992; 135: 1301-9.
9. Begg C B, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-101.
10. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34. (Pubitemid 27387172)
11. Kawai M, Minami Y, Kuriyama S, et al. Reproductive factors, exogenous female hormone use and breast cancer risk in Japanese: the Miyagi Cohort Study. Cancer Causes Control 2010; 21: 135-45.
12. Lee S Y, Kim M Y, Kim S W, et al. Effect of lifetime lactation on breast cancer risk: Korean women' s cohort study. Int J Cancer 2003; 105: 390-3. (Pubitemid 36570053)
13. Dumeaux V, Alsaker E, Lund E. Breast cancer and specific types of oral contraceptives: A large Norwegian cohort study. Int J Cancer 2003; 105: 844-50. (Pubitemid 36706110)
14. Wu M H, Chou YC, Yu J C, et al. Hormonal and bodysize factors in relation to breast cancer risk: A prospective study of 11,889 women in a low-incidence area. Ann Epidemiol 2006; 16: 223-9.
15. Hankinson SE, Colditz GA, Manson JE, et al. A prospective study of oral contraceptive use and risk of breast cancer (Nurses' Health Study, United States). Cancer Causes Control 1997; 8: 65-72. (Pubitemid 27092943)
16. Mills P K, Beeson W L, Phillips R L, Fraser G E. Prospective study of exogenous hormone use and breast cancer in Seventh-day Adventists. Cancer 1989; 64: 592-7.
17. Schuurman AG, van den Brandt PA, Goldbohm RA. Exogenous hormone use and the risk of postmenopausal breast cancer: Results from the Netherlands Cohort Study. Cancer Causes Control 1995; 6: 416-24.
18. Kumle M, Weiderpass E, Braaten T, et al. Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women' s Lifestyle and Health Cohort Study. Cancer Epidemiol Biomarkers Prev 2002; 11: 1375-81. (Pubitemid 35340372)
19. Hunter DJ, Colditz GA, Handkinson SE, et al. Oral contraceptive use and breast cancer: A prospective study of young women. Cancer Epidemiol Biomarkers Prev 2010; 19: 2496-502.
20. Dorjgochoo T, Shu X O, Li H L, et al. Use of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to 2006. Int J Cancer 2009; 124: 2442-9.
21. Dumeaux V, Fournier A, Lund E, Clavel-Chapelon F. Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women. Cancer Causes Control 2005; 16: 537-44. (Pubitemid 40933623)
22. Hannaford P C, Slevaraj S, Elliott A M, et al. Cancer risk among users of oral contraceptives: Cohort data from the Royal College of General Practitioner' s oral contraception study. BMJ 2007; 335: 651-4. (Pubitemid 47548456)
23. Van Hoften C, Burger H, Peeters P H, et al. Long-term oral contraceptive use increases breast cancer risk in women over 55 years of age: The DOM cohort. Int J Cancer 2000; 87: 591-4. (Pubitemid 30639821)
24. Beral V, Hermon C, Kay C, et al. Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46000 women from Royal College of General Practitioners' oral contraception study. BMJ 1999; 318: 96-100. (Pubitemid 29188927)
25. Vessey M, Yeates D, Flynn S. Factors affecting mortality in a large cohort study with special reference to oral contraceptive use. Contraception 2010; 82: 221-9.
26. Wingo P A, Austin H, Marchbank P A, et al. Oral contraceptives and the risk of death from breast cancer. Obstet Gynecol 2007; 110: 793-800. (Pubitemid 47508742)
27. B rohet R M, Goldgar D E, Easton D F, et al. Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: A report from EMBRSCE, GENEPSO, GEO-HEBON, and the IBCCS collaboration group. J Clin Oncol 2007; 25: 3831-6. (Pubitemid 47477257)
28. Grabrick DM, Hartmann LC, Cerhan JR, et al. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. JAMA 2000; 284: 1791-8.
29. Silvera S A, Miller A B, Rohan T E. Oral contraceptive use and risk of breast cancer among women with a family history of breast cancer: A prospective cohort study. Cancer Causes Control 2005; 16: 1059-63. (Pubitemid 41356003)
30. Rosenberg L, Boggs D A, Wise LA, et al. Oral contraceptive use and estrogen/progesterone receptor-negative breast cancer among African American women. Cancer Epidemiol Biomarkers Prev 2010; 19: 2073-9.
31. Lawson JS, Field AS, Champion S, et al. Low oestrogen receptor alpha expression in normal breast tissue underlies low breast cancer incidence in Japan. Lancet 1999; 354: 1787-8.
32. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53297 women with breast cancer and 100239 women without breast cancer from 54 epidemiologic studies. Lancet 1996; 347: 1713-27.
33. Kahlenborn C, Modugno F, Potter DM, et al. Oral contraceptive use as a risk factor for premenopausal breast cancer: A meta-analysis. Mayo Clin Proc 2006; 81: 1290-302. (Pubitemid 44484967)
34. Isaksson E, von Schoultz E, Odlind V, et al. Effects of oral contraceptives on breast epithelial proliferation. Breast Cancer Res Treat 2001; 65: 163-9. (Pubitemid 32193620)
35. Garcia y Narvaiza D, Navarrete M A, Falzoni R, et al. Effect of combined oral contraceptives on breast epithelial proliferation in young women. Breast J 2008; 14: 450-5.
36. Selby C. Sex hormone binding globulin: Origin, function and clinical significance. Ann Clin Biochem 1990; 27: 532-41. (Pubitemid 20377170)
37. Lagerlund M, Sparen P, Thurfjell E, et al. Predictors of non-attendance in a population-based mammography screening programme; socio-demographic factors and aspects of health behaviour. Eur J Cancer Prev 2000; 9: 25-33. (Pubitemid 30428439)
38. Manzoli L, De Vito C, Marzuillo C, et al. Oral contraceptives and venous thromboembolism: A systematic review and meta-analysis. Drug Saf 2012; 35: 191-205.
39. Baillargeon J P, M cClish D K, E ssah P A, et al. Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: A meta-analysis. J Clin Endocrinol Metab 2005; 90: 3863-70. (Pubitemid 41058144)
40. Collaboration Group on Epidemiological Studies of Ovarian Cancer, Beral V, Doll R, et al. Ovarian cancer and oral contraceptives: Collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 2008; 371: 303-14.
41. Burkman R, Schlesselman J J, Zieman M. Safety concerns and health benefits associated with oral contraception. Am J Obstet Gynecol 2004; 190: S5-22.